当前位置:首页 - 行情中心 - 南京医药(600713) - 财务分析 - 资产负债表

南京医药

(600713)

  

流通市值:65.63亿  总市值:66.75亿
流通股本:12.87亿   总股本:13.09亿

资产负债表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
流动资产:
货币资金2,305,395,534.944,562,612,055.881,159,037,620.222,461,628,969.23
应收票据及应收账款17,494,810,620.8212,582,396,506.1517,892,364,178.1115,654,020,297.91
其中:应收票据1,079,210,227.04572,086,054.27938,917,203.011,069,085,679.79
应收账款16,415,600,393.7812,010,310,451.8816,953,446,975.114,584,934,618.12
应收款项融资2,162,327,317.662,515,275,629.482,827,220,190.012,932,913,972.19
预付款项991,831,195.07889,508,713.42882,635,324.861,025,463,473.28
其他应收款合计810,848,658.59812,089,253.74719,609,065.66844,940,981.96
存货6,276,599,451.466,285,916,964.926,027,962,471.235,912,948,177.72
其他流动资产134,354,436.97160,062,617.01125,849,085.43129,939,037.3
流动资产平衡项目0000
流动资产合计30,516,521,104.427,807,861,740.629,634,677,935.5228,961,854,909.59
非流动资产:
长期股权投资70,054,150.7370,566,432.6368,647,113.8968,415,493.91
其他权益工具投资202,049,568.24212,900,078.14235,360,656.24188,184,526.24
投资性房地产88,888,834.9389,281,397.5593,899,226.9892,107,520.54
固定资产1,402,981,219.991,415,854,506.281,095,105,014.561,102,404,109.9
在建工程262,924,740.37237,272,905.69193,237,869.59138,651,402.32
使用权资产340,567,202.71232,079,672.03233,170,635.29238,263,476.07
无形资产211,278,511.8215,684,191.83216,076,787.53217,383,033.28
开发支出21,849,873.9518,437,891.7816,843,225.14-
商誉72,166,924.6572,166,924.6572,166,924.6572,166,924.65
长期待摊费用44,481,732.4644,630,61747,271,830.7546,401,791.14
递延所得税资产232,195,688.73243,434,087.67245,996,908.45227,662,488.23
其他非流动资产13,489,702.4213,456,486.67301,653,110.67301,955,186.89
非流动资产平衡项目0000
非流动资产合计2,962,928,150.982,865,765,191.922,819,429,303.742,693,595,953.17
资产平衡项目0000
资产总计33,479,449,255.3830,673,626,932.5232,454,107,239.2631,655,450,862.76
流动负债:
短期借款4,477,208,119.572,044,519,083.584,307,463,335.834,567,877,942.38
应付票据及应付账款10,059,399,785.6110,175,570,479.879,857,776,481.999,592,321,846.29
其中:应付票据2,598,019,480.882,824,699,028.162,169,594,359.892,414,825,985.69
应付账款7,461,380,304.737,350,871,451.717,688,182,122.17,177,495,860.6
合同负债276,044,079.98278,668,232.77205,679,565.78191,527,486.54
应付职工薪酬158,758,946.06240,577,997.14167,624,976.13159,821,030.54
应交税费177,370,549.38216,510,402.2189,560,503.18193,440,483.85
其他应付款合计2,773,775,735.042,003,792,287.232,884,546,039.262,111,177,078.47
一年内到期的非流动负债79,238,470.65980,609,433.81963,127,986.782,176,064,566.6
其他流动负债1,625,444,068.471,153,464,610.311,153,885,607.331,147,844,836.97
流动负债平衡项目0000
流动负债合计19,627,239,754.7617,093,712,526.9119,729,664,496.2820,140,075,271.64
非流动负债:
长期借款200,000,000200,000,000648,481,100648,481,100
应付债券5,113,621,407.025,139,167,483.94,049,409,462.993,022,655,686.32
租赁负债226,030,861.91116,178,710.59123,428,998.96116,478,812.81
递延收益273,563,417.15277,616,419.57281,746,332.82286,031,079.32
递延所得税负债32,434,136.1559,053,677.5475,080,460.9454,263,851.66
非流动负债平衡项目0000
非流动负债合计5,845,649,822.235,792,016,291.65,178,146,355.714,127,910,530.11
负债平衡项目0000
负债合计25,472,889,576.9922,885,728,818.5124,907,810,851.9924,267,985,801.75
所有者权益(或股东权益):
实收资本(或股本)1,309,326,0401,309,326,0401,309,326,0401,309,326,040
其他权益工具8,939,046.758,939,046.75--
资本公积2,467,121,972.62,465,733,066.472,464,095,970.022,461,968,462.9
减:库存股12,125,532.2620,903,333.621,924,340.421,924,340.4
其他综合收益95,418,435.44102,296,529.74116,881,567.4381,613,701.8
盈余公积322,368,865.27322,368,865.27278,488,716.62278,488,716.62
未分配利润2,827,627,765.52,650,266,792.492,565,401,778.762,434,840,611.66
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计7,018,676,593.36,838,027,007.126,712,269,732.436,544,313,192.58
少数股东权益987,883,085.08949,871,106.89834,026,654.84843,151,868.43
股东权益平衡项目0000
股东权益合计8,006,559,678.387,787,898,114.017,546,296,387.277,387,465,061.01
负债和股东权益合计33,479,449,255.3830,673,626,932.5232,454,107,239.2631,655,450,862.76
公告日期2025-04-302025-04-102024-10-312024-08-30
审计意见(境内)标准无保留意见
TOP↑